Epic Systems Corporation vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 72)
Epic Systems Corporation logo

Epic Systems Corporation

LeaderHealthcare

Electronic Health Records (EHR) & Healthcare Software

Epic Systems is the dominant EHR vendor in the U.S., used by over 300 million patients' records and deployed at more than 300 health systems including most major U.S. academic medical centers; privately held; generates over $4B in annual revenue;

AI VisibilityBeta
Overall Score
B72
Category Rank
#117 of 596
AI Consensus
74%
Trend
stable
Per Platform
ChatGPT
78
Perplexity
71
Gemini
77

About

Epic Systems Corporation is a healthcare software company founded in 1979 by Judith Faulkner and headquartered in Verona, Wisconsin. The company is the dominant vendor of electronic health record (EHR) systems in the United States, with its software used to manage records for more than 300 million patients across more than 300 major health systems, hospitals, and academic medical centers. Epic's EHR platform — known as EpicCare — is an integrated, comprehensive clinical and administrative system covering patient records, order entry, scheduling, billing, pharmacy, lab results, imaging, and population health management, all within a single longitudinal patient record architecture.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

72
Overall Score
90
#117
Category Rank
#2
74
AI Consensus
83
stable
Trend
stable
78
ChatGPT
92
71
Perplexity
93
77
Gemini
89
68
Claude
96
72
Grok
95

Key Details

Category
Electronic Health Records (EHR) & Healthcare Software
Enterprise
Tier
Leader
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.